CN100486638C - Medicament for treating hyperplasia of mammary glands - Google Patents
Medicament for treating hyperplasia of mammary glands Download PDFInfo
- Publication number
- CN100486638C CN100486638C CNB200610128308XA CN200610128308A CN100486638C CN 100486638 C CN100486638 C CN 100486638C CN B200610128308X A CNB200610128308X A CN B200610128308XA CN 200610128308 A CN200610128308 A CN 200610128308A CN 100486638 C CN100486638 C CN 100486638C
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- medicine
- pericarpium citri
- cyclomastopathy
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating mammary gland hyperplasia, which is prepared from the following raw materials (by weight proportion): pangolin scales, oyster shell, seaweed, sea tangle, burred tuber, zedoary, motherwort, epimeddium, deer horn, Bupleurum root, cyperus tuber, rhizoma corydalis, green tangerine orange peel, dried orange peel, pericarpium trichosanthis, seed of cowherb, sweetgum fruit, the beneficial effects of the invention include quick effect, short course of treatment, low recurrence rate, no toxic and side actions.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of cystic hyperplasia of breast, relate in particular to a kind of medicine for the treatment of cyclomastopathy.
Background technology
Cyclomastopathy is a kind of commonly encountered diseases of women, frequently-occurring disease, is a kind of general chronic disease, and sickness rate is up to 60%, and clinical manifestation is the benign disease of the non-tumor of a kind of non-inflammation of symptom with lump in breast, pain, the pathogenic factors complexity.Pathological characteristic according to cyclomastopathy, this disease can be divided into for three phases: (one) simple property cyclomastopathy: the early stage performance that is cyclomastopathy, show as cyclomastopathy, and a matter not hypertrophy or slight hypertrophy, be that mammary gland local organization lamellar thickens or diffusivity graininess buildup area, obscure boundary presses painful.Cyclomastopathy is common hyperplasia of mammary glands pathological changes, be more common in the child-bearing period women, (2) capsule cyclomastopathy: be the rational proliferative phase of breast disease, show as the breast duct epithelium in various degree among the hypertrophy companion ductule expand in various degree, the mammary gland partial thickening, ill-defined lump or a plurality of tuberosity that differs in size, have expand painful, sharp etc.(3) tumor-like lesion: claim the fibrosclerosis disease again, the tumor sample lump that fibrous tissue forms.Doctor trained in Western medicine thinks that primary disease is relevant with endocrine regulation; The traditional Chinese medical science thinks that paathogenic factor is a qi depression to blood stasis, Chong and Ren channel disorder etc.Western medical treatment is with hormone therapy, the painful treatment in town, operative treatment.Shortcoming is that side effect is big, relapse rate height, breast deformation etc.The traditional Chinese medical science is with activating blood circulation to dissipate blood stasis, and hard masses softening and resolving etc. are the Therapeutic Principle, and shortcoming is long the course of treatment, and it is slow to take effect.
Summary of the invention
The medicine that the purpose of this invention is to provide good, the with strong points treatment cyclomastopathy of a kind of therapeutic effect.
The present invention realizes above-mentioned purpose by the following technical solutions: a kind of medicine for the treatment of cyclomastopathy, and it is the medicament of being made by the raw material of following parts by weight:
Squama Manis 5～15 Concha Ostreaes 10～30 Sargassums 9～20 Thallus Laminariae (Thallus Eckloniae)s 9～20
Rhizoma sparganic 9～15 Rhizoma Curcumae 9～15 Herba Leonuris 10～20 Herba Epimedii 10～30
Cornu Cervi 6～15 Radix Bupleuri 9～20 Rhizoma Cyperis 6～18 Rhizoma Corydalis 10～30
Pericarpium Citri Reticulatae Viride 9～15 Pericarpium Citri Reticulataes 6～15 Fructus Trichosanthis 9～15 kings do not stay 9～15
Fructus Liquidambaris 9～15.
The medicine of treatment cyclomastopathy, the preferably medicament of making by the raw material of following parts by weight:
Squama Manis 8～12 Concha Ostreaes 20～30 Sargassums 15～20 Thallus Laminariae (Thallus Eckloniae)s 15～20
Rhizoma sparganic 12～15 Rhizoma Curcumae 12～15 Herba Leonuris 15～20 Herba Epimedii 15～25
Cornu Cervi 8～15 Radix Bupleuri 15～20 Rhizoma Cyperis 10～18 Rhizoma Corydalis 15～25
Pericarpium Citri Reticulatae Viride 10～12 Pericarpium Citri Reticulataes 10～12 Fructus Trichosanthis 12～15 kings do not stay 12～15
Fructus Liquidambaris 12～15.
The medicine of treatment cyclomastopathy, the most preferably medicament of making by the raw material of following parts by weight:
Squama Manis 10 Concha Ostreaes 30 Sargassums 20 Thallus Laminariae (Thallus Eckloniae)s 20
Rhizoma sparganic 15 Rhizoma Curcumae 15 Herba Leonuris 20 Herba Epimedii 20
Cornu Cervi 12 Radix Bupleuri 15 Rhizoma Cyperis 15 Rhizoma Corydalis 20
Pericarpium Citri Reticulatae Viride 12 Pericarpium Citri Reticulataes 12 Fructus Trichosanthis 15 kings do not stay 15
Fructus Liquidambaris 15.
Medicament of the present invention is a said dosage form on any pharmaceutics.
The preparation of common formulations:
1, mixture: above-mentioned each component drug is mixed, decoct with water leaching, behind fried liquid placement certain hour, leach insoluble matter, collect filtrate concentrating, the packing of concentrated solution cold filtration.
2, capsule: with above-mentioned each material medicine drying and crushing, mix, sieving incapsulates in the shell.
3, pill: above-mentioned each component drug is ground into smalls, adds Mel and make honeyed pill.
Among the present invention, Squama Manis is apt to away scurry, the priming focus of going directly, and stimulating the menstrual flow reaches network, with the circulation of qi promoting removing blood stasis, the softening the hard mass nuclear that disappears; Concha Ostreae is selected Concha Ostreae for use, and Concha Ostreae, Sargassum, Thallus Laminariae (Thallus Eckloniae) are strengthened the power of hard masses softening and resolving; Rhizoma sparganic, Rhizoma Curcumae, Herba Leonuri removing blood stasis, regulating menstruation relieves the pain; Herba Epimedii, Cornu Cervi warming and recuperating the kidney-YANG, Chong and Ren Meridians regulating; Logical the dredging of Radix Bupleuri a surname reaches, and associates with Pericarpium Citri Reticulatae Viride, Pericarpium Citri Reticulatae, Rhizoma Cyperi, Rhizoma Corydalis, and the depressed liver-energy dispersing and QI regulating pain relieving is arranged, and transfers the effect of smooth QI and blood; Fructus Trichosanthis clearing away stomach-heat collateral dredging, the eliminating stagnation subduing inflammation; The king does not stay, Fructus Liquidambaris is invigorated blood circulation lactogenesis, mass dissipating and swelling eliminating, and all medicines share hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, Chong and Ren Meridians regulating, regulating the flow of vital energy relieves the pain, lactogenesis detumescence, treating both the principal and secondary aspects of a disease, Chinese medicine instant effect of the present invention, short treating period, relapse rate be low, have no side effect.
The specific embodiment
The present invention enumerates 6 embodiment, and the parts by weight of each embodiment component see the following form:
| Component | Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | Embodiment 6 |
| Squama Manis | 10 | 5 | 10 | 15 | 8 | 12 |
| Concha Ostreae | 30 | 20 | 10 | 15 | 25 | 20 |
| Sargassum | 20 | 10 | 15 | 18 | 12 | 9 |
| Thallus Laminariae (Thallus Eckloniae) | 20 | 12 | 15 | 10 | 9 | 18 |
| Rhizoma sparganic | 15 | 12 | 10 | 9 | 12 | 15 |
| Rhizoma Curcumae | 15 | 9 | 10 | 15 | 12 | 10 |
| Herba Leonuri | 20 | 15 | 20 | 12 | 18 | 10 |
| Herba Epimedii | 20 | 25 | 10 | 30 | 25 | 15 |
| Cornu Cervi | 12 | 8 | 10 | 12 | 9 | 15 |
| Radix Bupleuri | 15 | 10 | 20 | 18 | 15 | 9 |
| Rhizoma Cyperi | 15 | 6 | 15 | 12 | 18 | 8 |
| Rhizoma Corydalis | 20 | 15 | 25 | 30 | 10 | 25 |
| Pericarpium Citri Reticulatae Viride | 12 | 9 | 12 | 15 | 10 | 15 |
| Pericarpium Citri Reticulatae | 12 | 6 | 15 | 10 | 12 | 10 |
| Fructus Trichosanthis | 15 | 9 | 15 | 12 | 10 | 12 |
| The king does not stay | 15 | 15 | 12 | 15 | 10 | 9 |
| Fructus Liquidambaris | 15 | 12 | 9 | 15 | 10 | 12 |
This group case is totally 87 examples, is cyclomastopathy with mammary gland infrared scan, breast molybdenum target X line, mammary gland color ultrasonic diagnosis all, gets rid of the breast tumor sexually transmitted disease (STD) and becomes, cyclomastopathy 42 examples wherein, cystic hyperplasia 35 examples, tumor-like lesion 10 examples.This group case 87 examples are and take the mixture that medicine of the present invention is made merely, dose: a 10～20ml, and a twice-daily, 15 days is a course of treatment, omnidistance 30 days.
Therapeutic outcome sees the following form:
| Cyclomastopathy | Cystic hyperplasia | Tumor-like lesion | Add up to | |
| Case | 42 examples | 35 examples | 10 examples | 87 examples |
| Cure | 37 examples | 30 examples | 5 examples | 72 examples |
| Effectively | 5 examples | 5 examples | 3 examples | 13 examples |
| Invalid | 0 example | 0 example | 2 examples | 2 examples |
As can be known from the above table, cure 72 examples, account for 82% of total routine number; Effective 13 examples account for 14% of total routine number; Invalid 2 examples account for 2% of total routine number; Total effective rate is 98%.
Claims (4)
1, a kind of medicine for the treatment of cyclomastopathy is characterized in that, the weight for preparing the crude drug of this medicine consists of:
Squama Manis 5～15 Concha Ostreaes 10～30 Sargassums 9～20 Thallus Laminariae (Thallus Eckloniae)s 9～20
Rhizoma sparganic 9～15 Rhizoma Curcumae 9～15 Herba Leonuris 10～20 Herba Epimedii 10～30
Cornu Cervi 6～15 Radix Bupleuri 9～20 Rhizoma Cyperis 6～18 Rhizoma Corydalis 10～30
Pericarpium Citri Reticulatae Viride 9～15 Pericarpium Citri Reticulataes 6～15 Fructus Trichosanthis 9～15 kings do not stay 9～15
Fructus Liquidambaris 9～15.
2, treat the medicine of cyclomastopathy according to claim 1, it is characterized in that, the weight for preparing the crude drug of this medicine consists of:
Squama Manis 8～12 Concha Ostreaes 20～30 Sargassums 15～20 Thallus Laminariae (Thallus Eckloniae)s 15～20
Rhizoma sparganic 12～15 Rhizoma Curcumae 12～15 Herba Leonuris 15～20 Herba Epimedii 15～25
Cornu Cervi 8～15 Radix Bupleuri 15～20 Rhizoma Cyperis 10～18 Rhizoma Corydalis 15～25
Pericarpium Citri Reticulatae Viride 10～12 Pericarpium Citri Reticulataes 10～12 Fructus Trichosanthis 12～15 kings do not stay 12～15
Fructus Liquidambaris 12～15.
3, as the medicine of treatment cyclomastopathy as described in the claim 2, it is characterized in that the weight for preparing the crude drug of this medicine consists of:
Squama Manis 10 Concha Ostreaes 30 Sargassums 20 Thallus Laminariae (Thallus Eckloniae)s 20
Rhizoma sparganic 15 Rhizoma Curcumae 15 Herba Leonuris 20 Herba Epimedii 20
Cornu Cervi 12 Radix Bupleuri 15 Rhizoma Cyperis 15 Rhizoma Corydalis 20
Pericarpium Citri Reticulatae Viride 12 Pericarpium Citri Reticulataes 12 Fructus Trichosanthis 15 kings do not stay 15
Fructus Liquidambaris 15.
4, as the medicine of treatment cyclomastopathy as described in any one of the claim 1-3, it is characterized in that described medicine is made said dosage form on any pharmaceutics.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610128308XA CN100486638C (en) | 2006-11-30 | 2006-11-30 | Medicament for treating hyperplasia of mammary glands |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610128308XA CN100486638C (en) | 2006-11-30 | 2006-11-30 | Medicament for treating hyperplasia of mammary glands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1970064A CN1970064A (en) | 2007-05-30 |
| CN100486638C true CN100486638C (en) | 2009-05-13 |
Family
ID=38111212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200610128308XA Expired - Fee Related CN100486638C (en) | 2006-11-30 | 2006-11-30 | Medicament for treating hyperplasia of mammary glands |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100486638C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103405725B (en) * | 2013-08-27 | 2015-09-09 | 山东大学 | A kind of Chinese medicine composition based on marine drug for the treatment of cyclomastopathy |
-
2006
- 2006-11-30 CN CNB200610128308XA patent/CN100486638C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1970064A (en) | 2007-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1061854C (en) | Medicinal preparation for treatment and prevention of gynopathy | |
| CN1302801C (en) | Compound traditional Chinese medicine formulation for curing hysteromyoma | |
| CN100509014C (en) | Medicament for treating mammitis | |
| CN105106852A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands and breast cancer | |
| CN102631513A (en) | Medicinal plaster for removing stasis, eliminating stagnation and relieving swelling and preparation method thereof | |
| CN103127438A (en) | Chinese medicinal preparation for treating rheumatic bone pain and preparation method | |
| CN103341096B (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
| CN102698132A (en) | External used medicine for treating tumor | |
| CN102579982A (en) | Externally-applied patch of for local point to treat gynecologic pelvic inflammatory disease and preparation method thereof | |
| CN100486638C (en) | Medicament for treating hyperplasia of mammary glands | |
| CN101085184A (en) | Traditional Chinese medicine for treating breast cancer | |
| CN105816832A (en) | Traditional Chinese medicine gel plaster for treating wind-cold lumbago and preparation method thereof | |
| CN1111046C (en) | Chinese medicine preparation for curing postpartum disease of woman | |
| CN103705632A (en) | Application of mammary aggregation dispersing tablets in preparation of medicines for treating penis hardening disease | |
| CN102743667A (en) | Quick-acting detoxifcation herpes zoster eliminating ointment | |
| CN103007050B (en) | External Chinese medicament for drawing out poison | |
| CN101612358A (en) | Anticancer dispersing paste and preparation method thereof | |
| CN113244363B (en) | Traditional Chinese medicine cake moxibustion for orthopedics department as well as preparation method and application thereof | |
| CN104127805A (en) | Traditional Chinese medicine preparation used for treating hyperplasia of mammary glands, preparation method and application thereof | |
| CN1298371C (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
| CN102406753B (en) | Chinese medicinal composition for treating Bi syndrome | |
| CN115887601B (en) | A composition for treating hemorrhoid and its preparation method | |
| CN105233187A (en) | External use finish treating breast diseases and preparation method thereof | |
| CN101301412B (en) | Capsules for soothing depression and dissipating binds | |
| CN100356957C (en) | Chinese medicinal plaster for treating mastoncus and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090513 Termination date: 20111130 |